Counterweight Ventures, LLC Biocryst Pharmaceuticals Inc Transaction History
Counterweight Ventures, LLC
- $132 Billion
- Q2 2024
A detailed history of Counterweight Ventures, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Counterweight Ventures, LLC holds 13,500 shares of BCRX stock, worth $102,330. This represents 0.06% of its overall portfolio holdings.
Number of Shares
13,500
Previous 13,500
-0.0%
Holding current value
$102,330
Previous $68.6 Million
21.65%
% of portfolio
0.06%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
258Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$151 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$142 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$95.3 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$70.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$66.9 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.41B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...